Drug product
Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99
D-0219-2019
Product summary
- Event
- Event 81505
- Status
- Terminated
- Classification
- Class III
- Quantity
- 18,895 bottles
- Official record key
drug-enforcement:D-0219-2019
Official wording
Reason: Container packaging defect.
Code information: Lot #: ZYCY, Exp. 04/11/2021
Distribution pattern: Within the United States
Derived failure modes
-
Labeling or packaging
packaging defect